Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Aurinia Pharmaceuticals (AUPH) Misses Q1 EPS by 26c
May 6, 2021 4:57 PM EDTAurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.40), $0.26 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $40 thousand.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
... More